159 related articles for article (PubMed ID: 32485903)
1. Downregulated Platelet miR-1233-5p in Patients with Alzheimer's Pathologic Change with Mild Cognitive Impairment is Associated with Aβ-Induced Platelet Activation via P-Selectin.
Lee BK; Kim MH; Lee SY; Son SJ; Hong CH; Jung YS
J Clin Med; 2020 May; 9(6):. PubMed ID: 32485903
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.
Dakterzada F; Targa A; Benítez ID; Romero-ElKhayat L; de Gonzalo-Calvo D; Torres G; Moncusí-Moix A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Alzheimers Res Ther; 2020 Dec; 12(1):163. PubMed ID: 33278902
[TBL] [Abstract][Full Text] [Related]
3. Profile of Pathogenic Proteins and MicroRNAs in Plasma-derived Extracellular Vesicles in Alzheimer's Disease: A Pilot Study.
Li F; Xie XY; Sui XF; Wang P; Chen Z; Zhang JB
Neuroscience; 2020 Apr; 432():240-246. PubMed ID: 32135232
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
5. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology.
Sierksma A; Lu A; Salta E; Vanden Eynden E; Callaerts-Vegh Z; D'Hooge R; Blum D; Buée L; Fiers M; De Strooper B
Mol Neurodegener; 2018 Oct; 13(1):54. PubMed ID: 30314521
[TBL] [Abstract][Full Text] [Related]
6. Beyond CSF and Neuroimaging Assessment: Evaluating Plasma miR-145-5p as a Potential Biomarker for Mild Cognitive Impairment and Alzheimer's Disease.
Wen Q; Wittens MMJ; Engelborghs S; van Herwijnen MHM; Tsamou M; Roggen E; Smeets B; Krauskopf J; Briedé JJ
ACS Chem Neurosci; 2024 Mar; 15(5):1042-1054. PubMed ID: 38407050
[TBL] [Abstract][Full Text] [Related]
7. MiRNA -483-5p as a Potential Noninvasive Biomarker for Early Detection of Alzheimer's Disease.
Sabry R; El Sharkawy RE; Gad NM
Egypt J Immunol; 2020 Jun; 27(2):59-72. PubMed ID: 33548978
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data.
Satoh J; Kino Y; Niida S
Biomark Insights; 2015; 10():21-31. PubMed ID: 25922570
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs 99b-5p/100-5p Regulated by Endoplasmic Reticulum Stress are Involved in Abeta-Induced Pathologies.
Ye X; Luo H; Chen Y; Wu Q; Xiong Y; Zhu J; Diao Y; Wu Z; Miao J; Wan J
Front Aging Neurosci; 2015; 7():210. PubMed ID: 26635599
[TBL] [Abstract][Full Text] [Related]
10. Identification of the Role of miR-142-5p in Alzheimer's Disease by Comparative Bioinformatics and Cellular Analysis.
Song J; Kim YK
Front Mol Neurosci; 2017; 10():227. PubMed ID: 28769761
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
12. MiR-409-5p as a Regulator of Neurite Growth Is Down Regulated in APP/PS1 Murine Model of Alzheimer's Disease.
Guo J; Cai Y; Ye X; Ma N; Wang Y; Yu B; Wan J
Front Neurosci; 2019; 13():1264. PubMed ID: 31849582
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of microRNA-4487/6845-3p in Alzheimer's disease pathologies is induced by Aβ25-35 triggered in SH-SY5Y cell.
Hu L; Zhang R; Yuan Q; Gao Y; Yang MQ; Zhang C; Huang J; Sun Y; Yang W; Yang JY; Min ZL; Cheng J; Deng Y; Hu X
BMC Syst Biol; 2018 Dec; 12(Suppl 7):119. PubMed ID: 30547775
[TBL] [Abstract][Full Text] [Related]
14. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.
Siedlecki-Wullich D; Català-Solsona J; Fábregas C; Hernández I; Clarimon J; Lleó A; Boada M; Saura CA; Rodríguez-Álvarez J; Miñano-Molina AJ
Alzheimers Res Ther; 2019 May; 11(1):46. PubMed ID: 31092279
[TBL] [Abstract][Full Text] [Related]
15. miR-98-5p Acts as a Target for Alzheimer's Disease by Regulating Aβ Production Through Modulating SNX6 Expression.
Li Q; Li X; Wang L; Zhang Y; Chen L
J Mol Neurosci; 2016 Dec; 60(4):413-420. PubMed ID: 27541017
[TBL] [Abstract][Full Text] [Related]
16. The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease.
Samadian M; Gholipour M; Hajiesmaeili M; Taheri M; Ghafouri-Fard S
Front Aging Neurosci; 2021; 13():641080. PubMed ID: 33790780
[TBL] [Abstract][Full Text] [Related]
17. Intermittent Hypoxia-Hyperoxia Training Improves Cognitive Function and Decreases Circulating Biomarkers of Alzheimer's Disease in Patients with Mild Cognitive Impairment: A Pilot Study.
Serebrovska ZO; Serebrovska TV; Kholin VA; Tumanovska LV; Shysh AM; Pashevin DA; Goncharov SV; Stroy D; Grib ON; Shatylo VB; Bachinskaya NY; Egorov E; Xi L; Dosenko VE
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671598
[TBL] [Abstract][Full Text] [Related]
18. Can mild cognitive impairment and Alzheimer's disease be diagnosed by monitoring a miRNA triad in the blood?
Wei ZD; Shetty AK
Aging Cell; 2022 Jun; 21(6):e13627. PubMed ID: 35537095
[TBL] [Abstract][Full Text] [Related]
19. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study.
Sørensen SS; Nygaard AB; Christensen T
Transl Neurodegener; 2016; 5():6. PubMed ID: 26981236
[TBL] [Abstract][Full Text] [Related]
20. Reduced miR-26b Expression in Megakaryocytes and Platelets Contributes to Elevated Level of Platelet Activation Status in Sepsis.
Szilágyi B; Fejes Z; Póliska S; Pócsi M; Czimmerer Z; Patsalos A; Fenyvesi F; Rusznyák Á; Nagy G; Kerekes G; Berhés M; Szűcs I; Kunapuli SP; Kappelmayer J; Nagy B
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
